- Home
- TELA vs CVKD Comparison
TELA vs CVKD Comparison
Compare TELA & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TELA
- CVKD
- Stock Information
- Founded
- TELA 2012
- CVKD 2022
- Country
- TELA United States
- CVKD United States
- Employees
- TELA N/A
- CVKD N/A
- Industry
- TELA Medical/Dental Instruments
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- TELA Health Care
- CVKD Health Care
- Exchange
- TELA Nasdaq
- CVKD Nasdaq
- Market Cap
- TELA 36.4M
- CVKD 29.5M
- IPO Year
- TELA 2019
- CVKD 2023
- Fundamental
- Price
- TELA $1.93
- CVKD $12.95
- Analyst Decision
- TELA Strong Buy
- CVKD Strong Buy
- Analyst Count
- TELA 4
- CVKD 1
- Target Price
- TELA $6.00
- CVKD $32.00
- AVG Volume (30 Days)
- TELA 86.9K
- CVKD 31.8K
- Earning Date
- TELA 08-11-2025
- CVKD 08-06-2025
- Dividend Yield
- TELA N/A
- CVKD N/A
- EPS Growth
- TELA N/A
- CVKD N/A
- EPS
- TELA N/A
- CVKD N/A
- Revenue
- TELA $71,217,000.00
- CVKD N/A
- Revenue This Year
- TELA $26.67
- CVKD N/A
- Revenue Next Year
- TELA $22.63
- CVKD N/A
- P/E Ratio
- TELA N/A
- CVKD N/A
- Revenue Growth
- TELA 12.78
- CVKD N/A
- 52 Week Low
- TELA $0.86
- CVKD $5.70
- 52 Week High
- TELA $5.18
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- TELA 59.11
- CVKD 49.39
- Support Level
- TELA $1.85
- CVKD $11.00
- Resistance Level
- TELA $1.94
- CVKD $13.24
- Average True Range (ATR)
- TELA 0.19
- CVKD 1.10
- MACD
- TELA -0.00
- CVKD 0.17
- Stochastic Oscillator
- TELA 72.58
- CVKD 73.97
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.